中基因抑制了扩散黑色素瘤细胞的休眠状态
bioRxiv : the preprint server for biology
|June 12, 2025
概括
中基因 (MDK) 通过禁用NR2F1来重新激活休眠的黑色素瘤细胞,从而促进转移. 准MDK和NR2F1可能会防止黑色素瘤的传播,并提高生存率.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 黑色素瘤转移通常来自休眠的扩散癌细胞 (DCC).
- NR2F1是已知的DCC休眠的驱动因素,但其在重新激活期间的调节尚不清楚.
- 了解DCC休眠机制对于预防黑色素瘤复发至关重要.
研究的目的:
- 阐明DCC从黑色素瘤的休眠状态中唤醒的机制.
- 研究Midkine (MDK) 在调节NR2F1依赖性黑色素瘤细胞休眠中的作用.
- 探索针对MDK和NR2F1治疗黑色素瘤的潜在治疗策略.
主要方法:
- 研究了MDK对NR2F1活动和DCC休眠的作用.
- 分析了p-p38/p-ERK比率和ALK依赖在MDK介导的休眠中断.
- 在人类淋巴结活检中检查了MDK和NR2F1表达.
- 在黑色素瘤小鼠模型中利用NR2F1激动剂和MDK抑制剂.
主要成果:
- MDK触发了一种自克林机制,使得DCC中NR2F1依赖的休眠状态被禁用.
- MDK的作用涉及p-p38/p-ERK比率的放松,部分依赖ALK.
- 在人类的DCC中,MDK和NR2F1是反向相关的;低的MDK/高的NR2F1与休眠相关.
- NR2F1激活抑制MDK驱动的mTORC1活动,并减少MDK高的DCC中的转移.
- 双重MDK抑制和NR2F1激活在黑色素瘤小鼠模型中改善了生存率.
结论:
- 通过破坏DCC休眠状态,MDK促进黑色素瘤转移.
- 人体淋巴结中MDK和NR2F1之间的逆相关性支持它们在休眠和转移中的作用.
- 联合MDK抑制和NR2F1激活代表了一种有前途的治疗策略,可以延长黑色素瘤DCC休眠期并预防转移.
更多相关视频
08:48An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
Published on: June 30, 2015
8.2K
06:09Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
8.7K
相关概念视频
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...